PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsHuman germline genome editing could be curbed by patent law

BioNews

Human germline genome editing could be curbed by patent law

Published 3 September 2021 posted in News and appears in BioNews 1111

Author

David Cansfield

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Patent laws could be used to restrict the use of genome editing technologies from being used to change the germline...

Patent laws could be used to restrict the use of genome editing technologies from being used to change the germline.

Researchers in the USA and Denmark suggest that this could be a way to impose an ethical framework in a complex field with inconsistent regulation. It could function as an additional layer of regulation or safeguarding in countries that have more permissive policies or simply lack relevant regulation.

'A lot of policymakers and medical practitioners are concerned with some of the genomic editing technologies... there is no international enforcement agency out there that's going to stop people from engaging in genetic medical tourism.' said co-author Jacob Sherkow, professor of law at the University of Illinois.

The suggestion follows the recent World Health Organisation report (see BioNews 1103) that explored the international governance tools for human genome editing and ultimately focused on national implementation of governance as a mechanism to control how and why human germline genome editing is implemented.

The paper, published in the Journal of the American Medical Association explains that patent protection allows patent holders to set ethical limits on the use of their intellectual property as part of the licensing process. This effectively excludes others from using the technology unless they agree to the ethical conditions, or face infringement lawsuits that could result in severe financial penalties. In the USA, the implementation of ethical licensing restrictions is growing and is already being used in CRISPR-based applications.

This approach has the advantage of potentially being more agile than legislation, which can be slow to make and difficult to keep adequately updated.

'It's not a complete solution by any means, as it relies on private interests to police the social harms of a private activity,' said Professor Sherkow, 'But patents present an opportunity to combine the tools of commercialisation and ethical behaviour in a manner not readily available in other enforcement mechanisms'.

However, setting limits on social policy in this way rather than through legislative processes could be viewed as undemocratic.

Sources and References

  • 30/08/2021
    JAMA
    Governing human germline editing through patent law
  • 01/09/2021
    DT Next
    Patent law may curb unethical human-genome editing
  • 30/08/2021
    University of Illinois
    Paper: Use patent law to curb unethical human-genome editing

Related Articles

PET BioNews
Comment
9 August 2021 • 2 minutes read

FILM: Changing the Human Genome – What Next for Germline Genome Editing?

by BioNews

This film documents a Progress Educational Trust event about the World Health Organisation's recent publications on human genome editing...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
6 August 2021 • 5 minutes read

Book Review: Human Germline Genome Modification and the Right To Science

by Jen Willows

Genome editing – it's something we report on almost every week in BioNews in one form or another, and CRISPR has become a media buzzword...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
16 July 2021 • 6 minutes read

Regulating genomics – the next decade

by Gemma Hobcraft

The implementation plan for 2021-2022 provides an insight as to how the National Genomic Health Strategy will begin to 'transform genomic healthcare over the next ten years'...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
12 July 2021 • 2 minutes read

WHO publishes guidelines for human genome editing

by Jen Willows

The World Health Organisation has released new guidelines for the governance of genome editing in humans...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Researchers grow mini human lungs to imitate COVID-19 infection

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

27 June 2022 • 2 minutes read

UK report reveals public attitudes to fertility, genomics and embryo research

27 June 2022 • 2 minutes read

Shortage of sperm donors despite men willing to donate

27 June 2022 • 2 minutes read

North East London CCG proposes offering three funded IVF cycles

27 June 2022 • 2 minutes read

Fibrosis drugs reverse ovarian ageing in mice

27 June 2022 • 2 minutes read

Gene implicated in motor neurone diseases discovered

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856